Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddy’s Laboratories informs about press release
Date: 03-09-2020Dr. Reddy’s Laboratories has informed that the Company enclosed a press release on ‘Dr. Reddy's Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the US Market’.
The above information is a part of company’s filings submitted to BSE.